Location: Jammu, Jammu and Kashmir India
Profession: Assistant Professor
Inspired by: The serious threat posed by the spread of drug-resistant malaria in Africa has been widely acknowledged. Chloroquine resistance is now almost universal, and resistance to the successor drug, sulfadoxine-pyrimethamine (SP), is growing rapidly. Combination therapy has been suggested as being an available and potentially lasting solution to this impending crisis. However, the current cost of combination therapy, and especially that of artemisinin combination therapy (ACT), is potentially a serious drawback, even if a significant part of its cost is passed on to the end-user. If the question of cost is not successfully addressed this could lead to adverse results from the deployment of combination therapy as first-line treatment.
|07/02||Spade to Spoon: an Agricultural Block Chain Solution for Farmer Using IoT Platform||Manufacturing/Robotics/Automation||375||1|
|06/30||Intelligent Blood Tester to Detect Malaria Parasitemia||Medical||1264||13|